Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001951523 | SCV002242851 | pathogenic | Gorlin syndrome; Medulloblastoma | 2021-09-16 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the SUFU gene has been identified. Loss-of-function variants in SUFU are known to be pathogenic (PMID: 22508808, 25403219). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individual(s) with nevoid basal-cell carcinoma syndrome-like phenotypes and severe cognitive impairment (PMID: 12068298). For these reasons, this variant has been classified as Pathogenic. |